88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

ESG \| HitGen Releases Its Inaugural Sustainability Report CHENGDU, China , July 4, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced the release of its inaugural sustainability ... 2025-07-04T Biotechnology Environmental Products & Services Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai SHANGHAI , July 4, 2025 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ... 2025-07-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance ... 2025-07-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results JILIN, China , July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer ... 2025-07-03T Banking/Financial Service Biotechnology Health Care/Hospital
MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform BOSTON , July 3, 2025 /PRNewswire/ -- MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii , PhD, MBA, ... 2025-07-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement BEIJING , July 3, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting ... 2025-07-03T Banking/Financial Service Biotechnology Cosmetics & Personal Care Internet Technology
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy HONG KONG , July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical ... 2025-07-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Novotech Earns Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs and small- mid-size ... 2025-07-03T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR exon20 ins A pproval follows the U.S. FDA's Priority Review and is supported ... 2025-07-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 Highlights: ... 2025-07-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2025

Suntek Computer Systems Limited.

All rights reserved